About Centrillion Technologies
Centrillion Technologies is a company based in Palo Alto (United States) founded in 2009. Centrillion Technologies has raised $94.6 million across 9 funding rounds from investors including HHS and WeDoctor. The company has 23 employees as of December 31, 2022. Centrillion Technologies offers products and services including VirusHunter Assays, Spatial Transcriptomics, Genotyping Services, ATOM Chips, and QuadCore DNA Sequencing. Centrillion Technologies operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and deCODE Genetics, among others.
- Headquarter Palo Alto, United States
- Employees 23 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Centrillion Technologies, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$94.6 M (USD)
in 9 rounds
-
Latest Funding Round
$55.6 M (USD), Series C
Jul 19, 2018
-
Investors
HHS
& 1 more
-
Employee Count
23
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Centrillion Technologies
Centrillion Technologies offers a comprehensive portfolio of products and services, including VirusHunter Assays, Spatial Transcriptomics, Genotyping Services, ATOM Chips, and QuadCore DNA Sequencing.
Assays for fast SARS-CoV-2 detection and sequencing.
Technology for quantitative RNA detection with spatial resolution.
Ligation-based assays for high-quality human genotyping results.
Chips for high-throughput detection of up to 384 samples.
Chips for accurate SARS-CoV-2 genome sequencing and variant tracking.
Funding Insights of Centrillion Technologies
Centrillion Technologies has successfully raised a total of $94.6M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $55.6 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Centrillion Technologies
Centrillion Technologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and WeDoctor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Online platform to find healthcare professionals
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Centrillion Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Centrillion Technologies
Investment portfolio details for Centrillion Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Centrillion Technologies
Detailed financials for Centrillion Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Centrillion Technologies Comparisons
Peer comparison for Centrillion Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Centrillion Technologies
Centrillion Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and deCODE Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Bioinformatics platform for genetic disease analysis is provided.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
Detailed competitors of Centrillion Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Centrillion Technologies
Complete news archive for Centrillion Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Centrillion Technologies
Centrillion Technologies was founded in 2009.
Centrillion Technologies is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Centrillion Technologies is a funded company, having raised a total of $94.6M across 9 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Centrillion Technologies is 23.
Developer of DNA chips and molecular assays. The company focused on developing sequencing and bioinformatics solutions for genomic analysis for applications in drug discovery and life sciences research. The platform is leveraging engineering and biochemistry knowledge to accelerate discovery and understand the genomes complexity. The solutions are targeted for sequencing, chromosome-scale sequencing, genotyping, and 3D gene expression.
Centrillion Technologies's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Centrillion Technologies offers VirusHunter Assays, Spatial Transcriptomics, Genotyping Services, ATOM Chips, and QuadCore DNA Sequencing.